Vir Biotechnology, Inc. VIR Accrued interest
Accrued interest at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s accrued interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s accrued interest?
- Vir Biotechnology, Inc. (VIR) reported accrued interest of $3.3M in Q1 2026.
- How has Vir Biotechnology, Inc.'s accrued interest changed year-over-year?
- Vir Biotechnology, Inc.'s accrued interest decreased by 38.9% year-over-year, from $5.4M to $3.3M.
- What is the long-term trend for Vir Biotechnology, Inc.'s accrued interest?
- Over 2 years (2023 to 2025), Vir Biotechnology, Inc.'s accrued interest has grown at a -5.1% compound annual growth rate (CAGR), from $4M to $3.6M.
- What does accrued interest mean?
- Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.